Schmelz, Karin
Toedling, Joern http://orcid.org/0000-0003-1471-1295
Huska, Matt http://orcid.org/0000-0002-0912-745X
Cwikla, Maja C. http://orcid.org/0000-0002-6679-5577
Kruetzfeldt, Louisa-Marie http://orcid.org/0000-0003-3630-3727
Proba, Jutta
Ambros, Peter F.
Ambros, Inge M.
Boral, Sengül
Lodrini, Marco
Chen, Celine Y. http://orcid.org/0000-0002-1579-024X
Burkert, Martin
Guergen, Dennis
Szymansky, Annabell http://orcid.org/0000-0003-4797-4526
Astrahantseff, Kathy http://orcid.org/0000-0002-7872-1997
Kuenkele, Annette
Haase, Kerstin http://orcid.org/0000-0002-0944-5618
Fischer, Matthias http://orcid.org/0000-0003-1363-1242
Deubzer, Hedwig E. http://orcid.org/0000-0002-6115-4893
Hertwig, Falk http://orcid.org/0000-0003-4784-6516
Hundsdoerfer, Patrick
Henssen, Anton G. http://orcid.org/0000-0003-1534-778X
Schwarz, Roland F. http://orcid.org/0000-0001-9155-4268
Schulte, Johannes H. http://orcid.org/0000-0003-0671-1201
Eggert, Angelika http://orcid.org/0000-0003-3476-8184
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (#01ZX1307, #01ZX1607)
Berlin Institute of Health (TERMINATE-NB CRG04 collaborative research project) and in the TransTumVar project
Article History
Received: 23 November 2020
Accepted: 18 October 2021
First Online: 23 November 2021
Competing interests
: The authors declare no competing interests, except for D.G. who is employed by Experimental Pharmacology and Oncology Berlin-Buch GmbH.